13 January 2017

During the New Years 2017 event of the Radboud university medical center, Jolanda de Vries was honored by Leon van Halder, chairmen of our executive board, with the “Radboud Medal″.

The Radboud Medal is the highest honor awarded annually to a person who has contributed significantly to the objective of the Radboudumc as top knowledge center for academic medicine and health.”

Jolanda de Vries, professor of translational tumor immunology, is working at the Dept. of Tumor Immunology. She established a clinical vaccination program in which tumor-associated antigens loaded on DCs are used to treat both melanoma and colon cancer patients. Major current projects are to translate the DC vaccination into various clinical settings. Recently she and her team obtained a budget of 20 million euros from the national basic health insurance to introducte the experimental treatment with a vaccine that reduced the risk of the recurrence of skin cancer. The treatment will be offered in Nijmegen, Amsterdam, Rotterdam and Zwolle and is led by Jolanda de Vries.

She was awarded this highest honor of our Radboudumc for her great individual merits as a trainer of physicians and researchers, excellent research and her broad commitment to the Radboudumc in general. 

Related news items


Laurens Verscheijden awarded doctorate degree 'cum laude'

19 January 2022

Laurens Verscheijden of the Department of Pharmacology and Toxicology, defended his PhD thesis, entitled "Mechanistic models for the prediction of brain drug exposure and response in the paediatric population: A virtual child reaching maturation.

read more

Aerobe exercise has a positive effect on brain function in Parkinson's disease patients

18 January 2022

Radboudumc researchers have shown that the brain function of patients with Parkinson's disease improved with regular exercise, which seems to strengthen the connections between different brain areas, while inhibiting brain shrinkage.

read more

Last call for nominations for the RIHS Awards 2021 Deadline for submission is 25 January 2022

18 January 2022

RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award, the Supervisor of the Year Award, and the RIHS Patient Involvement Award.

read more

Rogier Kievit and Geert Litjens both receive ERC Starting Grant of 1.5 million euros Board of Directors congratulates researchers on top grant

13 January 2022

Researchers Rogier Kievit and Geert Litjens were today festively welcomed by the Board of Directors, because of the ERC Starting Grants they both received. With these European top grants, they can each design an ambitious research project and put together their own research group.

read more

Improved AI will boost cancer research and cancer care Geert Litjens receives ERC Starting Grant

13 January 2022

Geert Litjens from Radboud university medical center has received a European Research Council (ERC) Starting Grant.

read more

Understanding fluctuation variation in cognitive abilities may provide insight into lifelong learning Rogier Kievit recieves ERC Starting Grant

13 January 2022

Rogier Kievit from Radboud university medical center has received a European Research Council (ERC) Starting Grant.

read more